Stay updated on Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe Study Details page now displays a 'No longer looking for participants' notice and adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a new Revision: v3.6.0 entry. The 'Intervention/Treatment' heading and the earlier 'Revision: v3.5.5' entry have been removed.SummaryDifference0.5%

- Check19 days agoChange DetectedThe study record’s revision label was updated to v3.5.5, reflecting an editorial update to the page. The previous revision label v3.5.4 was replaced.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a version update for the page's content or UI.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page’s displayed revision/version number in the footer was updated from v3.5.2 to v3.5.3, reflecting a minor site release update without altering the study details.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page header.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page.